(Q40048081)

16 September 2017

title

Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimester (English)

1 reference

16 September 2017

0 references

Akturk M

1

1 reference

16 September 2017

Altinova AE

2

1 reference

16 September 2017

Mert I

3

1 reference

16 September 2017

Buyukkagnici U

4

1 reference

16 September 2017

Sargin A

5

1 reference

16 September 2017

Arslan M

6

1 reference

16 September 2017

Danisman N

7

1 reference

16 September 2017

language of work or name

1 reference

1 July 2008

1 reference

Journal of Endocrinological Investigation

16 September 2017

published in

1 reference

16 September 2017

volume

31

1 reference

16 September 2017

issue

7

1 reference

16 September 2017

page(s)

610-613

1 reference

Visfatin/pre-B-cell colony-enhancing factor: a protein with various suggested functions

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03345611

Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345611

The release of the adipocytokine visfatin is regulated by glucose and insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345611

Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345611

Gestational diabetes and the incidence of type 2 diabetes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345611

Increased visfatin concentrations in women with gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345611

Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345611

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345611

Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345611

Increase in visfatin after weight loss induced by gastroplastic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345611

Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345611

Perinatal circulating visfatin levels in intrauterine growth restriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345611

The role of adipocytokines in insulin resistance in normal pregnancy: visfatin concentrations in early pregnancy predict insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345611

Maternal soluble tumour necrosis factor receptor type 2 (sTNFR2) and adiponectin are both related to blood pressure during gestation and infant's birthweight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345611

Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus

21 January 2018

1 reference

12 December 2020

Longitudinal variance of fat mass deposition during pregnancy evaluated by ultrasonography: the ratio of visceral fat to subcutaneous fat in the abdomen

1 reference

12 December 2020

Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function

1 reference

12 December 2020

Blood visfatin concentrations in normal full-term pregnancies

1 reference

12 December 2020

Role of visfatin, insulin-like growth factor-I and insulin in fetal growth

1 reference

12 December 2020

Visceral fatness and insulin sensitivity in women with a previous history of gestational diabetes mellitus

1 reference

12 December 2020

The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile

1 reference

12 December 2020

Decreased plasma visfatin concentrations in women with gestational diabetes mellitus

1 reference

12 December 2020

Serum visfatin increases with progressive beta-cell deterioration

1 reference

12 December 2020

Etiology and pathogenesis of gestational diabetes

1 reference

12 December 2020

Gestational diabetes mellitus

1 reference

12 December 2020

Visfatin Response to Glucose Is Reduced in Women With Gestational Diabetes Mellitus

1 reference

12 December 2020

Gestational Diabetes Mellitus

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03345611

1 reference

Dimensions Publication ID

16 September 2017

1006575814

0 references

1 reference